Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1253088

Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report


Vukoja, Damir; Jurić, Andrea; Erkapić, Zdravka; Pejić, Tomislav; Zovko, Željko; Juričić, Josipa; Pejić, Jelena; Ćorluka, Matea
Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report // Frontiers in pharmacology, 12 (2021), 684537, 11 doi:10.3389/fphar.2021.684537 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1253088 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report

Autori
Vukoja, Damir ; Jurić, Andrea ; Erkapić, Zdravka ; Pejić, Tomislav ; Zovko, Željko ; Juričić, Josipa ; Pejić, Jelena ; Ćorluka, Matea

Izvornik
Frontiers in pharmacology (1663-9812) 12 (2021); 684537, 11

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
COVID-19 ; SARS-CoV-2 ; coronavirus ; corticosteroids ; dexamethasone ; primary health care ; treatment

Sažetak
Even in 2021, coronavirus disease 2019 (COVID-19) remains a major global health concern, especially in developing countries. The burden of this disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which affects not only primary respiratory but also other organ systems, keeps rising as the pandemic continues. Primary health care centers are the first line where COVID-19 patients are managed and should be able to manage the vast majority of them successfully. In this paper, we present a case series and concept of beneficial management of even deteriorating and severe patients treated entirely in our primary health center. The management is based on well-timed and rational dexamethasone use, as well as on various other pharmacological and nonpharmacological treatments and interventions, and is supported by provided statistical data. According to the presented experience and positive outcomes achieved, it seems that even deteriorating and severe COVID-19 patients can be treated successfully to some extent or even completely in primary care settings. This kind of approach could be particularly beneficial in conditions of overload of higher-level health care institutions.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Profili:

Avatar Url Jelena Pejić (autor)

Avatar Url Damir Vukoja (autor)

Citiraj ovu publikaciju:

Vukoja, Damir; Jurić, Andrea; Erkapić, Zdravka; Pejić, Tomislav; Zovko, Željko; Juričić, Josipa; Pejić, Jelena; Ćorluka, Matea
Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report // Frontiers in pharmacology, 12 (2021), 684537, 11 doi:10.3389/fphar.2021.684537 (međunarodna recenzija, članak, znanstveni)
Vukoja, D., Jurić, A., Erkapić, Z., Pejić, T., Zovko, Ž., Juričić, J., Pejić, J. & Ćorluka, M. (2021) Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report. Frontiers in pharmacology, 12, 684537, 11 doi:10.3389/fphar.2021.684537.
@article{article, author = {Vukoja, Damir and Juri\'{c}, Andrea and Erkapi\'{c}, Zdravka and Peji\'{c}, Tomislav and Zovko, \v{Z}eljko and Juri\v{c}i\'{c}, Josipa and Peji\'{c}, Jelena and \'{C}orluka, Matea}, year = {2021}, pages = {11}, DOI = {10.3389/fphar.2021.684537}, chapter = {684537}, keywords = {COVID-19, SARS-CoV-2, coronavirus, corticosteroids, dexamethasone, primary health care, treatment}, journal = {Frontiers in pharmacology}, doi = {10.3389/fphar.2021.684537}, volume = {12}, issn = {1663-9812}, title = {Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report}, keyword = {COVID-19, SARS-CoV-2, coronavirus, corticosteroids, dexamethasone, primary health care, treatment}, chapternumber = {684537} }
@article{article, author = {Vukoja, Damir and Juri\'{c}, Andrea and Erkapi\'{c}, Zdravka and Peji\'{c}, Tomislav and Zovko, \v{Z}eljko and Juri\v{c}i\'{c}, Josipa and Peji\'{c}, Jelena and \'{C}orluka, Matea}, year = {2021}, pages = {11}, DOI = {10.3389/fphar.2021.684537}, chapter = {684537}, keywords = {COVID-19, SARS-CoV-2, coronavirus, corticosteroids, dexamethasone, primary health care, treatment}, journal = {Frontiers in pharmacology}, doi = {10.3389/fphar.2021.684537}, volume = {12}, issn = {1663-9812}, title = {Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report}, keyword = {COVID-19, SARS-CoV-2, coronavirus, corticosteroids, dexamethasone, primary health care, treatment}, chapternumber = {684537} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font